Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2− breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2
Senthil Damodaran, Ciara Catherine O'Sullivan, Ahmed M. Elkhanany, I.C. Anderson, Minal A. Barve, Sibel H. Blau and 6 more
- Rank
- 76 of 3,639
- Percentile
- top 2.1%
- Where
- Annals of Oncology, 2023
- Citations
- 50
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.